Purpose of this review of medical literature is to present the immediate side effects of
radiation therapy for head and neck cancer and their treatment. The likelihood and severity …

The epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor
tyrosine kinases, plays an important role in the control of cell growth and differentiation …

The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is frequently
mutated or overexpressed in a large number of tumors such as carcinomas or glioblastoma …

Head and neck cancer is the sixth most common cancer worldwide. At present, globally
about 650,000 new cases of squamous cell carcinoma of the head and neck (SCCHN) are …

PURPOSE: To report toxicity data from the first 13 consecutive patients with locally
advanced head and neck squamous cell carcinoma (LAHNSCC), ineligible for cisplatin …

We retrospectively reviewed acute toxicity with cetuximab and radiotherapy, comparing it
with a matched cisplatin group. The cetuximab group experienced significantly more toxicity …

Emerging evidence suggests the existence of a new mode of epidermal growth factor
receptor (EGFR) signaling in which activated EGFR undergoes nuclear translocation …

BACKGROUND: The addition of epidermal growth factor receptor (EGFR) inhibitors to
radiotherapy has produced increased locoregional control and has reduced mortality from …

Background Radiation dermatitis developing in patients receiving cetuximab concomitantly
with radiotherapy for locally advanced squamous cell carcinoma of the head and neck (LA …

Background: Rosacea-like papulopustular eruptions (rash) are considered the most frequent
toxicities associated with the use of inhibitors of the epidermal growth factor receptor …